AbbVie Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AbbVie Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2020 to Q4 2023.
  • AbbVie Inc. Operating Lease, Right-of-Use Asset for the quarter ending December 31, 2023 was $744M, a 0.95% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $744M +$7M +0.95% Dec 31, 2023 10-K 2024-02-20
Q4 2022 $737M -$25M -3.28% Dec 31, 2022 10-K 2024-02-20
Q4 2021 $762M -$133M -14.9% Dec 31, 2021 10-K 2023-02-17
Q4 2020 $895M Dec 31, 2020 10-K 2022-02-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.